Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 348 entries
View as:

A U.S. Registry of Eosinophilic Esophagitis Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care

Phase: N/A Priority: Normal
NCT ID: NCT06693531 Org: User:
Start: 11/22/24 End: 05/09/30 Due: 05/09/31

Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip

Phase: N/A Priority: Normal
NCT ID: NCT03304379 Org: User:
Start: 10/26/17 End: 11/09/20 Due: 11/09/21

Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)

Phase: N/A Priority: Normal
NCT ID: NCT01979016 Org: User:
Start: 12/31/13 End: 01/31/15 Due: 01/31/16

Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT02277769 Org: User:
Start: 11/30/14 End: 01/31/16 Due: 01/31/17

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06585410 Org: User:
Start: 01/02/25 End: 05/03/30 Due: 05/03/31

To Assess the Patients' Ability to Self-Administer Fasinumab

Phase: N/A Priority: Normal
NCT ID: NCT03491904 Org: User:
Start: 01/23/19 End: 12/15/20 Due: 12/15/21

Study of REGN4659 in Combination With Cemiplimab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT03580694 Org: User:
Start: 06/27/18 End: 12/04/19 Due: 12/04/20

Compassionate Use of Pozelimab in Patients With CD55-Deficient Protein-Losing Enteropathy

Phase: N/A Priority: Normal
NCT ID: NCT06003881 Org: User:
Start: - End: - Due: -

Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE)

Phase: N/A Priority: Normal
NCT ID: NCT04394351 Org: User:
Start: 09/01/20 End: 05/14/24 Due: 05/14/25

A Study to Evaluate Efficacy and Safety of Casirivimab+Imdevimab (Monoclonal Antibodies) for Prevention of COVID-19 in Immunocompromised Adolescents and Adults

Phase: N/A Priority: Normal
NCT ID: NCT05074433 Org: User:
Start: 10/25/21 End: 05/18/22 Due: 05/18/23

A Study to Determine the Efficacy and Safety of Fasinumab for the Treatment of Adults With Chronic Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT02620020 Org: User:
Start: 01/26/16 End: 09/13/17 Due: 09/13/18

Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD

Phase: N/A Priority: Normal
NCT ID: NCT00320775 Org: User:
Start: 06/30/05 End: 08/31/08 Due: 08/31/09

A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA)

Phase: N/A Priority: Normal
NCT ID: NCT05092347 Org: User:
Start: 08/02/22 End: 12/12/26 Due: 12/12/27

Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT02712008 Org: User:
Start: 03/02/16 End: 07/10/17 Due: 07/10/18

Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT03399786 Org: User:
Start: 01/18/18 End: 03/17/20 Due: 03/17/21

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Pozelimab in Combination With Cemdisiran in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04601844 Org: User:
Start: 11/16/20 End: 07/23/21 Due: 07/23/22

Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04315298 Org: User:
Start: 03/18/20 End: 09/02/20 Due: 09/02/21

Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT03088540 Org: User:
Start: 05/29/17 End: 04/18/25 Due: 04/18/26

Study of Dupilumab and Immune Responses in Adults With Atopic Dermatitis (AD)

Phase: N/A Priority: Normal
NCT ID: NCT02210780 Org: User:
Start: 08/05/14 End: 09/15/15 Due: 09/15/16

VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00036946 Org: User:
Start: 11/30/01 End: - Due: -

Sequential Ascending Dose Study to Assess the Safety and Tolerability of REGN668 (SAR231893) in Patients With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT01259323 Org: User:
Start: 12/31/10 End: 07/31/12 Due: 07/31/13

A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05828511 Org: User:
Start: 12/19/23 End: 11/02/35 Due: 11/02/36

Real-World Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05673967 Org: User:
Start: 01/09/23 End: 03/28/25 Due: 03/28/26

Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares

Phase: N/A Priority: Normal
NCT ID: NCT01459796 Org: User:
Start: 11/30/11 End: 06/30/13 Due: 06/30/14

A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00871559 Org: User:
Start: 06/30/09 End: 02/28/14 Due: 02/28/15